A Study of BEN301 Injection in the Treatment of Autoimmune Diseases
NCT07502859
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
24
Enrollment
OTHER
Sponsor class
Conditions
SSC RA SS IIM
Interventions
BIOLOGICAL:
CD4⁺ CAR⁺ Foxp3⁺ cells
BIOLOGICAL:
CD4⁺ CAR⁺ Foxp3⁺ cells
Sponsor
Beijing Boren Hospital